-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Mid-Morning market update: Markets mixed; Kroger tops Q2 views
Mid-Morning market update: Markets mixed; Kroger tops Q2 views
Following the market opening Friday, the Dow traded down 0.15% to 34,827.04 while the NASDAQ rose 0.32% to 15,296.61. The S&P also rose, gaining 0.03% to 4,494.53.
Leading and Lagging Sectors
Consumer discretionary shares gained 0.6% on Friday. Meanwhile, top gainers in the sector included $Greenlane Holdings Inc(GNLN.US)$, up 13% and $Onion Global(OG.US)$ up 8%.
In trading on Friday, real estate shares fell by 0.9%.
Top Headline
$The Kroger(KR.US)$ reported better-than-expected results for its second quarter on Friday.
Kroger reported quarterly earnings of $0.80 per share, beating analysts' estimates of $0.64 per share. The company's quarterly sales came in at $31.68 billion, versus expectations of $30.68 billion.
Kroger said it sees FY21 earnings of $3.25 to $3.35 per share, versus analysts' estimates of $3.06 per share.
Equities Trading UP
$IVERIC bio Inc(ISEE.US)$ shares shot up 65% to $14.32 after $Apellis Pharmaceuticals Inc(APLS.US)$ reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.
Shares of $Echo Global Logistics Inc(ECHO.US)$ got a boost, shooting 54% to $48.17 after the company agreed to be acquired by private equity firm The Jordan Company.
$Endo International(ENDP.US)$ shares were also up, gaining 54% to $3.23 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.
Equities Trading DOWN
Apellis Pharmaceuticals Inc. shares tumbled 46% to $30.01 after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.
Shares of $KAVL BRND INOVTN(KAVL.US)$ were down 41% to $6.00 after climbing over 20% on Thursday.
$Mersana Therapeutics Inc(MRSN.US)$ was down, falling 36% to $9.06.
Commodities
In commodity news, oil traded up 2% to $69.48, while gold traded down 0.2% to $1,795.90.
Silver traded down 0.1% Friday to $24.145 while copper rose 3.5% to $4.4355.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.1%, the Spanish Ibex Index fell 1.3% and the German DAX 30 gained 0.1%. Meanwhile, the London's FTSE 100 rose 0.1%, French CAC 40 slipped 0.1% and Italy's FTSE MIB slipped 0.6%.
French industrial production increased 0.3% in July, while Italy's industrial production rose 0.8% from a month ago in July. Annual consumer price inflation rate in Germany was confirmed at 3.9% in August.
The UK GDP expanded by 3.6% during the three months to July, while industrial production rose 1.2% in July. The UK trade deficit increased to GBP 3.1 billion in July from GBP 2.5 billion in the earlier month. Imports to the UK rose 1.1%, while exports slipped 0.1% from the previous month in July.
Economics
Producer prices for final demand rose 0.7% in August.
US wholesale inventories rose 0.6% month-over-month to $722 billion in July.
The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
Following the market opening Friday, the Dow traded down 0.15% to 34,827.04 while the NASDAQ rose 0.32% to 15,296.61. The S&P also rose, gaining 0.03% to 4,494.53.
上周五开盘后,道琼斯工业平均指数下跌0.15%,至34,827.04点;纳斯达克指数上涨0.32%,至15,296.61点。标准普尔500指数也上涨0.03%,至4,494.53点。
Leading and Lagging Sectors
领先和落后行业
Consumer discretionary shares gained 0.6% on Friday. Meanwhile, top gainers in the sector included $Greenlane Holdings Inc(GNLN.US)$, up 13% and $Onion Global(OG.US)$ up 8%.
非必需消费品类股周五上涨0.6%。与此同时,涨幅最大的是扇区包括在内$Greenlane Holdings Inc.(GNLN.US)$,上涨13%,$Onion Global(OG.US)$上涨8%。
In trading on Friday, real estate shares fell by 0.9%.
在周五的交易中,房地产类股下跌了0.9%。
Top Headline
头条新闻
$The Kroger(KR.US)$ reported better-than-expected results for its second quarter on Friday.
$克罗格(KR.US)$上周五,该公司公布了好于预期的第二季度业绩。
Kroger reported quarterly earnings of $0.80 per share, beating analysts' estimates of $0.64 per share. The company's quarterly sales came in at $31.68 billion, versus expectations of $30.68 billion.
克罗格公布的季度收益为每股0.80美元,超过分析师预期的每股0.64美元。该公司季度销售额为316.8亿美元,高于预期的306.8亿美元。
Kroger said it sees FY21 earnings of $3.25 to $3.35 per share, versus analysts' estimates of $3.06 per share.
克罗格表示,预计2011财年每股收益为3.25美元至3.35美元,高于分析师预期的3.06美元。
Equities Trading UP
股票交易价格上涨
$IVERIC bio Inc(ISEE.US)$ shares shot up 65% to $14.32 after $Apellis Pharmaceuticals Inc(APLS.US)$ reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.
$IVERIC BIO Inc.(ISEE.US)$股价飙升65%,至14.32美元,此前$Apellis PharmPharmticals Inc.(APLS.US)$报告了其在地理萎缩方面的第三阶段德比和橡树研究结果。Apellis的竞争对手IVERIC Bio也在开发一种治疗地理萎缩的产品,名为Zimura。Stifel以买入评级启动了IVERIC Bio的报道,并宣布目标价为22美元。
Shares of $Echo Global Logistics Inc(ECHO.US)$ got a boost, shooting 54% to $48.17 after the company agreed to be acquired by private equity firm The Jordan Company.
的股份$Echo全球物流公司(ECHO.US)$在该公司同意被私募股权公司The Jordan Company收购后,该公司股价上涨54%,至48.17美元。
$Endo International(ENDP.US)$ shares were also up, gaining 54% to $3.23 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.
$远藤国际(ENDP.US)$股价也上涨了54%,至3.23美元,此前该公司表示,已就纽约州萨福克县最高法院悬而未决的三起合并阿片类药物案件达成和解。作为和解的结果,远藤已被切断与审判的联系。
Equities Trading DOWN
股票交易价格下跌
Apellis Pharmaceuticals Inc. shares tumbled 46% to $30.01 after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.
Apellis PharmPharmticals Inc.股价暴跌46%,至30.01美元,此前该公司公布了3期德比和橡树研究的喜忧参半的结果,该研究评估了1,258名继发于老年性黄斑变性的地理萎缩成年人的玻璃体内注射聚乙二醇胺计划。Oaks的研究达到了每月和每隔一个月使用pegcetaco计划治疗的主要终点,显示出与12个月的合并Sham相比,GA皮损的增长分别显著减少了22%和16%。然而,德比研究没有达到GA病变增长的主要终点,与12个月的联合Sham相比,每月和每隔一个月的治疗分别减少了12%和11%。
Shares of $KAVL BRND INOVTN(KAVL.US)$ were down 41% to $6.00 after climbing over 20% on Thursday.
的股份$KAVL BRND INOVTN(KAVL.US)$在周四攀升逾20%后,股价下跌41%,至6.00美元。
$Mersana Therapeutics Inc(MRSN.US)$ was down, falling 36% to $9.06.
$Mersana治疗公司(MRSN.US)$下跌36%,至9.06美元。
Commodities
商品
In commodity news, oil traded up 2% to $69.48, while gold traded down 0.2% to $1,795.90.
大宗商品新闻方面,油价上涨2%,至每桶69.48美元,而黄金下跌0.2%,至每桶1,795.90美元。
Silver traded down 0.1% Friday to $24.145 while copper rose 3.5% to $4.4355.
上周五,银价下跌0.1%,至每盎司24.145美元,铜价上涨3.5%,至每盎司4.4355美元。
Euro zone
欧元区
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.1%, the Spanish Ibex Index fell 1.3% and the German DAX 30 gained 0.1%. Meanwhile, the London's FTSE 100 rose 0.1%, French CAC 40 slipped 0.1% and Italy's FTSE MIB slipped 0.6%.
欧洲股市今天大多走低。欧元区STOXX 600指数下跌0.1%,西班牙IBEX指数下跌1.3%,德国DAX 30指数上涨0.1%。与此同时,伦敦富时100指数上涨0.1%,法国CAC 40指数下跌0.1%,意大利富时MIB指数下跌0.6%。
French industrial production increased 0.3% in July, while Italy's industrial production rose 0.8% from a month ago in July. Annual consumer price inflation rate in Germany was confirmed at 3.9% in August.
法国7月工业生产增长0.3%,意大利7月工业生产较前月增长0.8%。德国8月份的年度消费者价格通胀率被确认为3.9%。
The UK GDP expanded by 3.6% during the three months to July, while industrial production rose 1.2% in July. The UK trade deficit increased to GBP 3.1 billion in July from GBP 2.5 billion in the earlier month. Imports to the UK rose 1.1%, while exports slipped 0.1% from the previous month in July.
在截至7月份的三个月里,英国GDP增长了3.6%,而7月份工业生产增长了1.2%。英国7月份的贸易逆差从前一个月的25亿英镑增加到31亿英镑。7月份,英国进口增长1.1%,出口环比下滑0.1%。
Economics
经济学
Producer prices for final demand rose 0.7% in August.
8月份最终需求的生产者价格上涨了0.7%。
US wholesale inventories rose 0.6% month-over-month to $722 billion in July.
美国7月批发库存环比增长0.6%,至7,220亿美元。
The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
贝克休斯最近一周的北美钻机数量报告定于下午1点发布。Et.
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧